Meningococcal Seroepidemiology 1 Year After the PsA-TT Mass Immunization Campaign in Burkina Faso

Background. A group A meningococcal (MenA) conjugate vaccine, PsA-TT (MenAfriVac), was introduced in Burkina Faso via mass campaigns between September and December 2010, targeting the 1- to 29-year-old population. This study describes specific antibody titers in the general population 11 months late...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Tall, Haoua, Yaro, Seydou, Kpoda, Hervé B. N., Ouangraoua, Soumeya, Trotter, Caroline L., Njanpop Lafourcade, Berthe-Marie, Findlow, Helen, Bai, Xilian, Martin, Catherine, Nwakamma, Ikenna, Ouedraogo, Jean Bosco, Gessner, Bradford D., Borrow, Ray, Mueller, Judith E.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639492/
https://ncbi.nlm.nih.gov/pubmed/26553686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ519
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados